Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
US Army
Express Scripts
Chinese Patent Office
Federal Trade Commission
Farmers Insurance
Daiichi Sankyo

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207071

« Back to Dashboard
NDA 207071 describes FINACEA , which is a drug marketed by Bayer Hlthcare and is included in one NDA. It is available from four suppliers. There are seven patents protecting this drug. Additional details are available on the FINACEA profile page.

The generic ingredient in FINACEA is azelaic acid. There are eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the azelaic acid profile page.

Summary for NDA: 207071

Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 207071

Suppliers and Packaging for NDA: 207071

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
azelaic acid
AEROSOL, FOAM;TOPICAL 207071 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-829 50419-829-01 1 CAN in 1 CARTON (50419-829-01) > 50 g in 1 CAN
azelaic acid
AEROSOL, FOAM;TOPICAL 207071 NDA Bayer HealthCare Pharmaceuticals Inc. 50419-829 50419-829-71 1 CAN in 1 CARTON (50419-829-71) > 30 g in 1 CAN

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, FOAM;TOPICALStrength15%
Approval Date:Jul 29, 2015TE:RLD:Yes
Patent:6,730,288Patent Expiration:Sep 8, 2019Product Flag?YSubstance Flag?Delist Request?
Patent:7,700,076Patent Expiration:Sep 18, 2027Product Flag?YSubstance Flag?Delist Request?
Patent:8,722,021Patent Expiration:Oct 24, 2023Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Queensland Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus